MARKET

LGND

LGND

Ligand Pharma
NASDAQ
59.34
+0.02
+0.03%
Opening 14:15 09/22 EDT
OPEN
59.28
PREV CLOSE
59.32
HIGH
59.93
LOW
58.70
VOLUME
42.39K
TURNOVER
0
52 WEEK HIGH
97.65
52 WEEK LOW
47.76
MARKET CAP
1.03B
P/E (TTM)
40.88
1D
5D
1M
3M
1Y
5Y
Jazz Pharma wins EU approval for blood cancer therapy
Seeking Alpha · 4h ago
Ligand (LGND) to Spin Out Pelican Subsidiary, Updates '23 View
NASDAQ · 3d ago
Ligand Pharma Updates Annual Guidance As It Spins Out Pelican Subsidiary
Benzinga · 3d ago
Where Ligand Pharmaceuticals Stands With Analysts
Benzinga · 3d ago
HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target
Benzinga · 3d ago
H.C. Wainwright Reaffirms Their Buy Rating on Ligand Pharma (LGND)
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Virpax Pharmaceuticals (VRPX)
TipRanks · 3d ago
Craig-Hallum Reaffirms Their Buy Rating on Ligand Pharma (LGND)
TipRanks · 3d ago
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company. The Company is focused on acquiring or funding programs and technologies that pharmaceutical companies use to discover and develop medicines. The Company’s Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Its Pelican Expression technology is a scalable platform for recombinant protein production, and is especially suited for complex, large-scale protein production. The Company’s products include Kyprolis, Teriparatide, Evomela, Rylaze, Nexterone, Pneumosil, Vaxneuvance, and Other. Kyprolis is formulated with Ligand’s Captisol technology. Teriparatide Injection is a drug indicated for uses including the treatment of osteoporosis in certain patients at high risk for fracture. Evomela is a Captisol-enabled melphalan IV formulation. Its other products include Pneumosil, Rylaze, Nexterone, Veklury, Zulresso, and Noxafil-IV.

Webull offers kinds of Ligand Pharmaceuticals Inc stock information, including NASDAQ:LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.